BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Zong X, Huang J, Guan Y, Li Y, Du T, Liu K, Kang X, Dou C, Sun X, Wu R, Wen L, Zhang Y. Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice. Aging (Albany NY) 2019;11:5008-34. [PMID: 31314744 DOI: 10.18632/aging.102095] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Yang D, Jiang Y, Wang Y, Niu M, Wang C, Luo H, Xu H, Li J, Zhang YW, Zhang X. Loss of RAB39B does not alter MPTP-induced Parkinson's disease-like phenotypes in mice. Front Aging Neurosci 2023;15:1087823. [PMID: 36761179 DOI: 10.3389/fnagi.2023.1087823] [Reference Citation Analysis]
2 Zhang W, Huang J, Gao F, You Q, Ding L, Gong J, Zhang M, Ma R, Zheng S, Sun X, Zhang Y. Lactobacillus reuteri normalizes altered fear memory in male Cntnap4 knockout mice. EBioMedicine 2022;86:104323. [PMID: 36395738 DOI: 10.1016/j.ebiom.2022.104323] [Reference Citation Analysis]
3 Feng H, Xue M, Deng H, Cheng S, Hu Y, Zhou C. Ginsenoside and Its Therapeutic Potential for Cognitive Impairment. Biomolecules 2022;12:1310. [PMID: 36139149 DOI: 10.3390/biom12091310] [Reference Citation Analysis]
4 Gong L, Yin J, Zhang Y, Huang R, Lou Y, Jiang H, Sun L, Jia J, Zeng X. Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases. Front Pharmacol 2022;13:914352. [PMID: 35721176 DOI: 10.3389/fphar.2022.914352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yadav D, Kumar P. Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics. Neurochem Int 2022;156:105327. [PMID: 35331828 DOI: 10.1016/j.neuint.2022.105327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Lim JS, Kim CR, Shin KS, Lee SJ, Yoon TJ, Park HJ. Synergistic effect of Korean red ginseng extract and GABA mixture on the IgE production in mice via Th1/Th2 cell balance. Food Sci Biotechnol 2021;30:1571-80. [PMID: 34868705 DOI: 10.1007/s10068-021-00985-x] [Reference Citation Analysis]
7 Gong J, Zhang W, Ding L, Zhang M, Zheng S, Ma R, Tang J, Yi W, Xu H, Zhang Y. 4,4'-Dimethoxychalcone regulates redox homeostasis by targeting riboflavin metabolism in Parkinson's disease therapy. Free Radic Biol Med 2021;174:40-56. [PMID: 34332078 DOI: 10.1016/j.freeradbiomed.2021.07.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhang W, Xiong BR, Zhang LQ, Huang X, Yuan X, Tian YK, Tian XB. The Role of the GABAergic System in Diseases of the Central Nervous System. Neuroscience 2021;470:88-99. [PMID: 34242730 DOI: 10.1016/j.neuroscience.2021.06.037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
9 Li X, Wang W, Yan J, Zeng F. Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson's Disease. Front Neurosci 2021;15:678154. [PMID: 34220434 DOI: 10.3389/fnins.2021.678154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Han L, Lu J, Tang Y, Fan Y, Chen Q, Li L, Liu F, Wang J, Zuo C, Zhao J. Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson's Disease. Front Aging Neurosci 2021;13:627356. [PMID: 33664663 DOI: 10.3389/fnagi.2021.627356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kang Z, Zhonga Y, Wu T, Huang J, Zhao H, Liu D. Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease. Pharmacol Rep 2021;73:700-11. [PMID: 33462754 DOI: 10.1007/s43440-020-00213-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Song Y, Gong T, Xiang Y, Mikkelsen M, Wang G, Edden RAE. Single-dose L-dopa increases upper brainstem GABA in Parkinson's disease: A preliminary study. J Neurol Sci 2021;422:117309. [PMID: 33548666 DOI: 10.1016/j.jns.2021.117309] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Liu Y, Wang S, Kan J, Zhang J, Zhou L, Huang Y, Zhang Y. Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling. Curr Neuropharmacol 2020;18:260-76. [PMID: 31686629 DOI: 10.2174/1570159X17666191101125530] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
14 Zhang W, Zhou M, Lu W, Gong J, Gao F, Li Y, Xu X, Lin Y, Zhang X, Ding L, Zhang Z, Li G, Chen X, Sun X, Zhu X, Xu P, Zhang Y. CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. Theranostics 2020;10:3000-21. [PMID: 32194851 DOI: 10.7150/thno.40798] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
15 Zhang Y, Meng X, Jiao Z, Liu Y, Zhang X, Qu S. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra. ACS Chem Neurosci 2020;11:406-17. [PMID: 31909584 DOI: 10.1021/acschemneuro.9b00609] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
16 Liu Y, Du T, Zhang W, Lu W, Peng Z, Huang S, Sun X, Zhu X, Chen C, Qian L, Wen L, Xu P, Zhang Y. Modified Huang-Lian-Jie-Du Decoction Ameliorates Aβ Synaptotoxicity in a Murine Model of Alzheimer's Disease. Oxid Med Cell Longev 2019;2019:8340192. [PMID: 31781354 DOI: 10.1155/2019/8340192] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]